Onkologie. 2012:6(2):91-95

Therapy for Ewing´s Family of Tumours in adults

Dagmar Adámková Krákorová1, Štěpán Tuček1, Jiří Tomášek1, Pavel Janíček2, Jaromír Černý2
1 Klinika komplexní onkologické péče, LF Masarykovy univerzity a Masarykův onkologický ústav Brno
2 I. ortopedická klinika, LF Masarykovy univerzity a FN u sv. Anny v Brně

Ewing´s Family of Tumours is most frequently observed in children and adolescent age. 90 % of patiens are younger than 20 years. Prognosis

is unfavourable, with 5-year overall survival from 55 to 70 % in localized, not exceeding 20 % in primarily metastatic disease. The

results of the therapy are getting worse by increasing age. Multidisciplinary treatment planning is mandatory in all cases of this tumor.

We introduce our experience with EURO E.W.I.N.G. 99/EWING 2008 protocol in adult patients.

Keywords: Ewing´s Family of Tumours, multimodal therapy, toxicity, survival

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Adámková Krákorová D, Tuček Š, Tomášek J, Janíček P, Černý J. Therapy for Ewing´s Family of Tumours in adults. Onkologie. 2012;6(2):91-95.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bleyer WA, Barr RD. Cancer in Adolescents and Young Adults, Bone Cancer. Springer - Verlag 2007: 203-215. Go to original source...
    2. Bleyer WA, O´Leary M, Barr R, Ries, et al. Cancer epidemiology in Older Adolescents and Young Adults 15 to 29 years of Age, including SEER Incidence and Survival, 1975-2000. National Cancer Institute, 2006, NIH Pub. No 06-5767, Bethesda MD, www.seer.cancer.gov/publications.
    3. Balamuth NJ, Wormer RB. Ewing´s sarcoma. Lancet 2010; 11: 184-192. Go to original source... Go to PubMed...
    4. Schleiermacher G, Peter M, Berlin O, et al. Increased risk of systemic relaps associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing sarcoma tumor. J Clin Oncol 2003; 21: 85-91. Go to original source... Go to PubMed...
    5. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing´s tumor of bone: analysis of 975 patient from European Intergroup Cooperative Ewing´s Sarcoma Study Group. J Clin Oncol 2000; 18: 3108-3114. Go to original source... Go to PubMed...
    6. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing´s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348: 694-701. Go to original source... Go to PubMed...
    7. Paulussen M, Ahrens S, Juergens HF. Cure rates in Ewing tumor patient aged over 15 years are better in pediatric oncology units. Results of GPOH CESS/EICESS studies. Proc Am Soc Clin Oncol 2003; 22: 816.
    8. Engelhardt M, Zeiser R, Ihorst G, et al. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patiens with high-risk or advanced Ewing and soft tissue sarcoma. J Cancer Res Clin Oncol 2007; 133(1): 1-11. Go to original source... Go to PubMed...
    9. Pieper S, Ranft A, Braun-Munzinger G, et al. Ewing´s tumor ower the age of 40: a retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G.99. Onkologie 2008; 657-663. Go to original source... Go to PubMed...
    10. Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in nonmetastatic Ewing´s sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Insituto Ortopedico Rizzoli. J Clin Oncol 2000; 18: 4-11. Go to original source... Go to PubMed...
    11. Bacci G, Ferrari S, Mercuri M, et al. Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis. J Pediatr Hematol Oncol, 2003, 25: 118-124. Go to original source... Go to PubMed...
    12. Kruseová J, Sumerauer D, Stejskalová E, et al. Diagnostické a léčebné postupy u nádorů ze skupiny Ewingův sarkom/periferní neuroepiteliální tumor (ES/PNET) u dětí a mladistvých. Klinická onkologie 2006; 6: 293-298.
    13. NCCN Clinical Practise Guidlines in Oncology, Bone Cancer V. 2/2011. www: nccn.org.
    14. Mudry P. Cílená terapie u kostních sarkomů. Onkológia 2011; 6(2): 89-91.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.